ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN
MLPR
1 hedge funds and large institutions have $3.71K invested in ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0.03% less ownership
Funds ownership: 0.04% → 0.01% (-0.03%)
75% less capital invested
Capital invested by funds: $15K → $3.71K (-$11.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.5K |
MLPR Hedge Fund Activity: Q4 2022 in Review
1 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN (MLPR) for Q4 2022, worth a combined $3.71K — down 75% from $15K a quarter earlier.
Fund positioning in MLPR was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $12.5K.
- 1 institutional investor held ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN (MLPR) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $3.71K of ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN stock for Q4 2022, down 75% quarter-over-quarter.
- 0 funds opened new ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN positions in Q4 2022 and 0 closed out.
- The largest ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN seller in Q4 2022 was UBS Group, an estimated $12.5K sold.
Based on aggregated 13F filings for Q4 2022.